SCHEMBL418337

SCHEMBL418337

COC(=O)c1cccc(-c2cccc3cccnc23)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC40A1 Q9NP59 2/20 0.57
ALOX15 P16050 1/20 0.55
HTT P42858 1/20 0.55
SERPINE1 P05121 1/20 0.53
ALDH1A1 P00352 3/20 0.50
CDK8 P49336 1/20 0.50
HPGD P15428 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
NEK1 Q96PY6 2/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
AXL P30530 1/20 0.49
PDE4A P27815 2/20 0.47
PDE4B Q07343 1/20 0.47
PDE4C Q08493 1/20 0.47
PDE4D Q08499 1/20 0.47
ABL1 P00519 1/20 0.47
BCR P11274 1/20 0.47
SRC P12931 1/20 0.47
BRD4 O60885 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2951217 0.86 ALDH1A1 (0.58) SLC40A1ALOX15HTTALDH1A1HPGD
SCHEMBL7439637 0.84 PDE4A (0.54) SLC40A1ALOX15HTTCDK8PDE4A
SCHEMBL8444023 0.84 TGFBR1 (0.53) ALOX15HTTALDH1A1CDK8HPGD
SCHEMBL5558505 0.83 ALDH1A1 (0.52) SLC40A1ALOX15HTTALDH1A1CDK8
Hydrochloric Acid SCHEMBL7443954 0.83 PDE4A (0.53) SLC40A1ALOX15HTTCDK8PDE4A
SCHEMBL420673 0.83 PDE4A (0.54) SLC40A1SERPINE1PDE4APDE4BPDE4C
SCHEMBL28267408 0.82 PDE4A (0.62) SLC40A1SERPINE1CDK8NPC1RAB9A
SCHEMBL16502605 0.82 ALOX15 (0.56) SLC40A1ALOX15HTTALDH1A1HPGD
SCHEMBL418419 0.81 SERPINE1 (0.77) SERPINE1L3MBTL1NPC1RAB9ALMNA
SCHEMBL2083887 0.80 ERN1 (0.52) ALOX15HTTALDH1A1CDK8HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2607348-B1 Plasminogen Activator Inhibitor-1 Inhibitor RENASCIENCE INC (JP) 2021-03-17 EP disclosed
CN-102378753-B Plasminogen activator-1 inhibitor RENASCIENCE Co.,Ltd. (JP) 2016-03-02 CN disclosed
US-20140296256-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO LTD (JP) 2014-10-02 US disclosed
US-8785473-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2014-07-22 US disclosed
EP-2607348-A2 Plasminogen Activator Inhibitor-1 Inhibitor Renascience CO., LTD. (JP) 2013-06-26 EP disclosed
EP-2415755-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR Renascience CO., LTD. (JP) 2012-02-08 EP disclosed
US-20120022080-A1 Plasminogen Activator Inhibitor-1 Inhibitor RENASCIENCE CO., LTD. (JP) 2012-01-26 US disclosed
CN-1070173-C Benzoylguanidine derivatives as medicaments FUJISAWA PHARMACEUTICAL CO (JP) 2001-08-29 CN disclosed
CN-1158606-A Benzoylguanidine derivatives as medicaments FUJISAWA PHARMACEUTICAL CO (JP) 1997-09-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296256-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SLC40A1 2142/4885ALOX15 596/4885HTT 1191/4885
US-20120022080-A1 Plasminogen Activator Inhibitor-1 Inhibitor SERPINE1, SERPINC1, SERPINB1 SLC40A1 2142/4885ALOX15 596/4885HTT 1191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.